$IDXX

15 stories mentioning IDXXUpdated 2d ago

Every FINWIRES story that references IDXX, newest first.

What are analysts saying about IDXX?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on IDXX?

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Economic Data, Fed Rate Hike

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 1.3% and the actively traded Invesco QQQ Trust (QQQ) was 1.8% higher in Thursday's premarket activity amid economic data releases as traders digest the Federal Reserve's interest rate hike.US stock futures were also higher, with S&P 500 Index futures up 0.8%, Dow Jones Industrial Average futures advancing 0.8%, and Nasdaq futures gaining 1.1% before the start of regular trading.US initial jobless claims fell to a level of 196,000 in the employment survey week ended Sept. 12 from an unrevised 206,000 level in the previous week, compared with expectations for an increase to 207,000 in a survey of analysts compiled by Bloomberg.The Philadelphia Federal Reserve's monthly manufacturing index fell to 37.8 in September after rising to 47.4 in August, compared with expectations for a larger decrease to a reading of 32.1 in a survey compiled by Bloomberg.August housing starts fell by 2.6% from the previous month to a 1.275 million annual rate, below expectations compiled by Bloomberg as of 7:35 am ET for a 1.32 million rate after a decrease to a 1.309 million pace in July.Pending home sales data for August are due to be released at 10 am ET, followed by weekly natural gas stocks data at 10:30 am ET.In premarket activity, bitcoin was up by 0.2%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was flat, Ether ETF (EETH) advanced 0.9%, and Bitcoin & Ether Market Cap Weight ETF (BETH) was 0.4% lower.Power Play:IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) advanced 1.3%, while the Vanguard Industrials Index Fund (VIS) was up 0.6% and the iShares US Industrials ETF (IYJ) was flat.Generac (GNRC) stock was 29% higher, a day after the company said it had signed a long-term supply agreement with Amazon (AMZN) to provide backup power generators for data centers.Winners and Losers:EnergyThe iShares US Energy ETF (IYE) was 1.2% lower, while the State Street Energy Select Sector SPDR ETF (XLE) was down by 0.5%.Fluence Energy (FLNC) shares were down 22% after the company lowered its fiscal 2026 revenue guidance, citing ongoing supply chain issues impacting its US production.TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) advanced 1.5%, the iShares US Technology ETF (IYW) was 0.9% higher, and the iShares Expanded Tech Sector ETF (IGM) was inactive. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) gained 1.5%, while the iShares Semiconductor ETF (SOXX) rose by 2.4%.Vicor (VICR) shares were up more than 12% in premarket activity after the company said it granted a nonexclusive license to a new AI original equipment manufacturer licensee with the right to procure Vertical Power Delivery modules covered by company patents from unlicensed suppliers.FinancialThe State Street Financial Select Sector SPDR ETF (XLF) advanced 0.4%. Direxion Daily Financial Bull 3X Shares (FAS) was up 1.4%, while its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), was 1.4% lower.Affirm (AFRM) shares were up 5% after the company said it launched a new transformer-based underwriting model that is now live at checkout in the US.Health CareThe State Street Health Care Select Sector SPDR ETF (XLV) advanced 0.1%, the Vanguard Health Care Index Fund (VHT) was up 0.7%, while the iShares US Healthcare ETF (IYH) was inactive. The iShares Biotechnology ETF (IBB) was 0.3% higher.IDEXX Laboratories (IDXX) stock was up more than 1% premarket after the company said it has expanded its Faecal Dx antigen testing platform in the UK to detect taeniid tapeworms, including Taenia and Echinococcus species.ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) was up 0.1%, the Vanguard Consumer Staples Index Fund ETF Shares (VDC) was down 0.1%, and the iShares US Consumer Staples ETF (IYK) was inactive. The State Street Consumer Discretionary Select Sector SPDR ETF (XLY) gained 0.8%. The VanEck Retail ETF (RTH) was inactive, while the State Street SPDR S&P Retail ETF (XRT) advanced 0.6%.Nike (NKE) stock were 1.5% higher after the company said late Wednesday that Alexandre Arnault has been appointed to its board.CommoditiesFront-month US West Texas Intermediate crude oil retreated by 2.3% to $100.11 per barrel on the New York Mercantile Exchange. Natural gas was down 0.4% at $2.88 per 1 million British Thermal Units. The United States Oil Fund (USO) decreased by 2.3%, while the United States Natural Gas Fund (UNG) was 0.3% lower.Gold futures for November retreated by 0.1% to $4,385.30 an ounce on the Comex. Silver futures gained by 0.3% to reach $65.09 an ounce. SPDR Gold Shares (GLD) was up by 2.3%, and the iShares Silver Trust (SLV) rose by 3.4%.

Dow JonesNasdaq CompositeS&P 500$AFRM$AMZN$FAS$FAZ$FLNC$GLD$GNRC$IBB$IDXX$IGM$IYE$IYH$IYJ$IYK$IYW$NKE$QQQ$RTH$SLV$SOXX$SPY$UNG$USO$VDC$VHT$VICR$VIS$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD

Sectors2d ago

Sector Update: Healthcare Stocks Edge Higher Pre-Bell Thursday

Healthcare stocks were edging higher pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.6% and the iShares Biotechnology ETF (IBB) advancing by 1.3%.Nuvation Bio (NUVB) stock was up more than 3% after the company said the FDA has approved its supplemental New Drug Application for IBTROZI (taletrectinib), a ROS1 inhibitor for locally advanced or metastatic ROS1-positive non-small cell lung cancer.Indivior Pharmaceuticals (INDV) shares were up more than 3% after the company said its board has declared a special cash dividend of $8.13 per share to holders of record as of Oct. 30.IDEXX Laboratories (IDXX) has expanded its Faecal Dx antigen testing platform in the UK to detect taeniid tapeworms, including Taenia and Echinococcus species, the company said. IDEXX Laboratories stock was up more than 1% premarket.

$IBB$IDXX$INDV$NUVB$XLV

Sectors39d ago

Sector Update: Healthcare Stocks Mixed Premarket Tuesday

Healthcare stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) marginally declining and the iShares Biotechnology ETF (IBB) advancing by 0.3%.IDEXX Laboratories (IDXX) shares were up more than 3% after the company launched the Catalyst proBNP Test, a dual-species in-clinic test for NT-proBNP designed to help veterinarians assess heart disease in cats and dogs.Legend Biotech (LEGN) stock was up more than 4% after the company reported that it swung to Q2 earnings as revenue increased during the period.Cardinal Health (CAH) shares were up 0.9% after the company posted higher fiscal Q4 non-GAAP earnings and revenue.

$CAH$IBB$IDXX$LEGN$XLV

Sectors39d ago

Sector Update: Healthcare

Healthcare stocks were flat to higher premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) inactive and the iShares Biotechnology ETF (IBB) advancing by 0.3%.IDEXX Laboratories (IDXX) shares were up more than 3% after the company launched the Catalyst proBNP Test, a dual-species in-clinic test for NT-proBNP designed to help veterinarians assess heart disease in cats and dogs.

$IDXX

Sectors46d ago

Sector Update: Healthcare Stocks Decline Premarket Tuesday

Healthcare stocks were declining premarket Tuesday, with the iShares Biotechnology ETF (IBB) and State Street Health Care Select Sector SPDR ETF (XLV) down 0.1%.Merck (MRK) shares were up more than 1% after the company posted an increase in Q2 sales and raised its 2026 sales outlook.BioNTech (BNTX) stock was down more than 3% after the company reported a wider Q2 adjusted loss and lower revenue, and cut its 2026 revenue guidance.IDEXX Laboratories (IDXX) shares were up more than 7% after the company raised its 2026 EPS outlook.

$BNTX$IBB$IDXX$MRK$XLV

Commodities46d ago

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Amid Strait of Hormuz Re-Opening Hopes

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.3% and the actively traded Invesco QQQ Trust (QQQ) was 1.1% higher in Tuesday's premarket activity amid hopes for a re-opening of the Strait of Hormuz after US Treasury Secretary Scott Bessent told CNBC that the US and Iran could reach a deal Tuesday or Wednesday.US stock futures were also higher, with S&P 500 Index futures up 0.3%, Dow Jones Industrial Average futures advancing 1.1%, and Nasdaq futures gaining 1.1% before the start of regular trading.The US international trade deficit narrowed to $73.26 billion in June from a $77.65 billion gap in May, a slightly larger deficit than the expectations for a $73 billion gap in a survey compiled by Bloomberg as of 7:30 am ET.Factory orders and job openings data for June are due to be released at 10 am ET.In premarket activity, bitcoin was down by 0.1%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was flat, Ether ETF (EETH) retreated 0.01%, and Bitcoin & Ether Market Cap Weight ETF (BETH) was flat.Power Play:TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) advanced 2.2%, the iShares US Technology ETF (IYW) was 1.9% higher, and the iShares Expanded Tech Sector ETF (IGM) was up 1.6%. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) gained 1.2%, while the iShares Semiconductor ETF (SOXX) rose by 4.4%.Palantir Technologies (PLTR) shares were up more than 15% in Tuesday's premarket activity after multiple analyst price target raises followed the company's Q2 beat.Winners and Losers:IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) advanced 1.6%, while the Vanguard Industrials Index Fund (VIS) was up 0.7% and the iShares US Industrials ETF (IYJ) was 0.8% higher.Caterpillar (CAT) shares were up 11% after the company reported higher Q2 earnings and revenue.Health CareThe State Street Health Care Select Sector SPDR ETF (XLV) retreated 0.1%, the Vanguard Health Care Index Fund (VHT) advanced marginally by 0.02%, while the iShares US Healthcare ETF (IYH) was inactive. The iShares Biotechnology ETF (IBB) was down 0.3%.IDEXX Laboratories (IDXX) stock was up 4% premarket after the company posted higher Q2 comparable earnings and revenue.EnergyThe iShares US Energy ETF (IYE) gained 1%, while the State Street Energy Select Sector SPDR ETF (XLE) was down by 0.8%.Energy Transfer (ET) stock was up more than 4% before market open after the company reported higher Q2 earnings and revenue.FinancialThe State Street Financial Select Sector SPDR ETF (XLF) declined by 0.2%. Direxion Daily Financial Bull 3X Shares (FAS) was down 0.7%, while its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), was 0.4% higher.TOP Financial (TOP) shares were up 4% in early hours activity after the company said its board has approved a plan to integrate artificial intelligence into its online brokerage and financial technology platforms.ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) was down 0.4%, the Vanguard Consumer Staples Index Fund ETF Shares (VDC) retreated 0.04%, and the iShares US Consumer Staples ETF (IYK) was inactive. The State Street Consumer Discretionary Select Sector SPDR ETF (XLY) lost 0.4%. The VanEck Retail ETF (RTH) was inactive, while the State Street SPDR S&P Retail ETF (XRT) was 0.4% higher.NIKE (NKE) shares were down more than 3% pre-bell after JPMorgan downgraded the company's stock to underweight from neutral and cut its price target to $40 from $47.CommoditiesFront-month US West Texas Intermediate crude oil fell by 2.8% to $78.07 per barrel on the New York Mercantile Exchange. Natural gas was down 3% at $2.70 per 1 million British Thermal Units. The United States Oil Fund (USO) decreased by 2.7%, while the United States Natural Gas Fund (UNG) was 2.3% lower.Gold futures for November advanced by 0.7% to $4,119.50 an ounce on the Comex. Silver futures gained by 2.7% to reach $59.41 an ounce. SPDR Gold Shares (GLD) was up by 0.7%, and the iShares Silver Trust (SLV) was 3% higher.

Dow JonesNasdaq CompositeS&P 500$BETH$BITO$CAT$EEM$EETH$ET$EXI$FAS$FAZ$GLD$IBB$IDXX$IGM$IGV$IPK$IVV$IWM$IYE$IYH$IYJ$IYK$IYW$NKE$PLTR$PMR$QQQ$RTH$SLV$SOXX$SPY$TOP$UNG$USO$VDC$VHT$VIS$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD

Wire54d ago

Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says

Elanco Animal Health (ELAN) seems "best-positioned name" into the Q2 print, with IDEXX Laboratories (IDXX) appearing to be "more de-risked than compelling" and Zoetis (ZTS) looking safe rather than having a high upside, UBS said in its animal health preview note Monday.Elanco's accelerating momentum in US pet health segment through May, along with its Credelio Quattro product share gains, support a revenue beat for the quarter and guidance raise, UBS analysts said. They added that solid Q2 results, an increase in revenue for its innovation segment, and a positive outlook for H2 should drive up shares.For IDEXX, a recurring revenue beat in its companion animal group segment and an increase in placements for inVue product should help drive good results, the analysts said. They stated that stabilization of vet visits plus a clearer product catalyst at the company's Aug. 13 investor day would help boost sentiment on the stock further.Zoetis looks to have a limited downside currently, but for "meaningful" upside, the company needs a "cleaner" Q2 beat, a guidance reset that inspires more confidence, and more clarity on the pipeline in the next two years, the analysts said.UBS kept Elanco's stock rating at buy and price target at $31, maintained IDEXX's stock rating at neutral and cut its price target to $620 from $640, and reiterated Zoetis' stock rating at neutral and reduced its price target to $85 from $99.Price: $25.33, Change: $+0.41, Percent Change: +1.67%

$ELAN$IDXX$ZTS

Wire54d ago

UBS Cuts IDEXX Laboratories Price Target to $620 From $640, Maintains Neutral Rating

IDEXX Laboratories (IDXX) has an average rating of overweight and mean price target of $713.46, according to analysts polled by FactSet.Price: $561.04, Change: $+16.71, Percent Change: +3.07%

$IDXX

Research137d ago

Research Alert: CFRA Keeps Hold Rating On Shares Of Idexx Laboratories, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target to $612 from $620, based on 37.3x our 2027 EPS estimate, below IDXX's historical forward P/E averages. We slightly raise our 2026 EPS view to $14.70 from 14.67. We keep our 2027 view at $16.42. IDXX reported a solid Q1, exceeding expectations, with revenue of $1.141B (+11% Y/Y organic) due to strong performance in its Companion Animal Group Diagnostics recurring revenue. However, we see IDXX facing risks in the near term stemming from macroeconomic pressures on consumers that are causing a decline in discretionary wellness-related veterinary visits. This trend poses a financial risk, as IDXX full-year guidance assumes a 1.5% decline in U.S. clinical visits; thus, a further worsening of the economic environment could lead to steeper declines and challenge revenue targets. Additionally, IDXX flagged a minor supply chain disruption in the Middle East, which, while contained, underscores the potential for broader operational risks within global business activities.

$IDXX

Sectors137d ago

Sector Update: Health Care Stocks Higher Pre-Bell Tuesday

Health care stocks were higher premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) gaining by 0.1% and the iShares Biotechnology ETF (IBB) advancing 0.2%.IDEXX Laboratories (IDXX) shares rose more than 3% pre-bell after the company reported higher Q1 comparable earnings and revenue.Waters (WAT) shares were over 10% higher pre-bell after the company reported higher fiscal Q1 adjusted earnings and revenue.Fresenius Medical Care (FMS) stock was down more than 5% premarket after the company reported lower Q1 earnings and revenue.

$FMS$IBB$IDXX$WAT$XLV

Sectors137d ago

Sector Update: Health Care

$IBB$IDXX$XLV

Research137d ago

Research Alert: Idexx Posts Solid Q1 Fueled By Innovation And Strong Cag Group Performance

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:IDEXX posted strong Q1 results with EPS of $3.47 (+17% Y/Y), beating expectations by $0.06, while revenue reached $1.141B (+14% Y/Y), $30M above consensus. CAG Diagnostics recurring revenue grew 14% Y/Y to $920M, demonstrating resilient demand for core diagnostic solutions. Operating margin expanded 10 bps to 31.8%, supported by strong recurring revenue gains and operational productivity initiatives. International markets showed particular strength with CAG revenue growing 22.7% compared to 11% domestically, highlighting successful global expansion efforts, in our view. The 12% expansion in the global premium instrument installed base and 20% growth in VetLab consumables underscore continued innovation adoption. Management raised the full-year 2026 guidance, reflecting confidence in the business trajectory, in our view: IDXX sees 2026 sales in the range of $4.675B-4.760B vs. prior $4.632B-$4.720B, representing +8.6%-10.6% Y/Y growth and EPS of $14.45-$14.90 vs. prior $14.29-$14.80, reflecting +11%-14% Y/Y.

$IDXX

Commodities137d ago

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Amid Corporate Earnings Rush

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively traded Invesco QQQ Trust (QQQ) advanced 0.6% in Tuesday's premarket activity amid a rush of corporate earnings.US stock futures were also higher, with S&P 500 Index futures up 0.4%, Dow Jones Industrial Average futures advancing 0.3%, and Nasdaq futures gaining 0.6% before the start of regular trading.International trade data for March will be released at 8:30 am ET, followed by S&P global services data for April at 9:45 am ET.ISM manufacturing data for April, job openings data for March, and new home sales data for March are all due at 10 am ET.Federal Reserve Vice Chair for Supervision Michelle Bowman and Fed Governor Michael Barr are slated to speak on Tuesday.In premarket activity, bitcoin was up by 1.1%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 1.3% higher, Ether ETF (EETH) advanced 1%, and Bitcoin & Ether Market Cap Weight ETF (BETH) was flat.Power Play:IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) advanced 0.3%, while the Vanguard Industrials Index Fund (VIS) rose 1.7%, and the iShares US Industrials ETF (IYJ) was inactive.Sterling Infrastructure's (STRL) stock was up more than 25% before the opening bell after the company overnight reported a stronger-than-expected rise in Q1 earnings and sales, and guided fiscal 2026 sales above analyst expectations.Winners and Losers:ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) gained 0.01% and the Vanguard Consumer Staples Index Fund ETF Shares (VDC) was up 0.6%. The iShares US Consumer Staples ETF (IYK) was inactive. The State Street Consumer Discretionary Select Sector SPDR ETF (XLY) advanced 0.3%. The VanEck Retail ETF (RTH) was inactive, while the State Street SPDR S&P Retail ETF (XRT) was 0.7% higher.Anheuser-Busch InBev (BUD) shares were up more than 6% pre-bell after the company reported higher fiscal Q1 underlying earnings and revenue.EnergyThe iShares US Energy ETF (IYE) was inactive, while the State Street Energy Select Sector SPDR ETF (XLE) was up by 0.1%.Kosmos Energy (KOS) stock was down more than 1% before the opening bell after the company reported a Q1 adjusted loss versus analysts' expectations of earnings.Health CareThe State Street Health Care Select Sector SPDR ETF (XLV) advanced 0.1%, the Vanguard Health Care Index Fund (VHT) gained 0.5%, while the iShares US Healthcare ETF (IYH) was flat. The iShares Biotechnology ETF (IBB) was 0.2% higher.IDEXX Laboratories (IDXX) stock was up more than 3% premarket after the company reported higher Q1 comparable earnings and revenue.FinancialThe State Street Financial Select Sector SPDR ETF (XLF) advanced 0.4%. Direxion Daily Financial Bull 3X Shares (FAS) was up 0.5%, while its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), was 0.2% lower.HSBC (HSBC) shares were down more than 3% pre-bell after the company reported lower-than-expected Q1 earnings.TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) gained 0.8%, and the iShares US Technology ETF (IYW) was flat, while the iShares Expanded Tech Sector ETF (IGM) was up 0.3%. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) was 1.9% higher, while the iShares Semiconductor ETF (SOXX) rose by 1.4%.Leidos Holdings (LDOS) shares were up more than 2% in Tuesday's premarket activity after the company reported higher Q1 non-GAAP earnings and revenue.CommoditiesFront-month US West Texas Intermediate crude oil retreated by 2.4% to $103.92 per barrel on the New York Mercantile Exchange. Natural gas was down by 1.3% at $2.83 per 1 million British Thermal Units. The United States Oil Fund (USO) fell by 1.1%, while the United States Natural Gas Fund (UNG) was 0.8% lower.Gold futures for May gained by 0.9% to reach $4,573.50 an ounce on the Comex. Silver futures advanced by 0.9% to $74.20 an ounce. SPDR Gold Shares (GLD) was 1% higher, and the iShares Silver Trust (SLV) rose by 1.1%.

Dow JonesNasdaq CompositeS&P 500$BETH$BITO$BUD$EEM$EETH$EXI$FAS$FAZ$GLD$HSBC$IBB$IDXX$IGM$IGV$IPK$IVV$IWM$IYE$IYH$IYJ$IYK$IYW$KOS$LDOS$PMR$QQQ$RTH$SLV$SOXX$SPY$STRL$UNG$USO$VDC$VHT$VIS$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD

Research151d ago

Research Alert: CFRA Lowers Rating On Shares Of Idexx Laboratories, Inc. To Hold From Buy

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We cut our target to $620, 37.8x our 2027 EPS estimate, below IDXX's historical forward P/E averages. We reduce our 2026 EPS view to $14.67 from $14.73 and keep our 2027 view at $16.42. We think the company is entering a transitional period marked by leadership change while the uncertainty in the current economic environment may constrain veterinary visits and pet owners' spend. In January 2026, the company announced that Michael Erickson, who has been with IDXX since 2011, will assume the role of President and CEO on May 12, 2026, succeeding the long-tenured CEO Jay Mazelsky, who will move to Executive Chair before retiring in May 2027. While pet owners continue to prioritize their companion animals' health, with pet-care costs rising above inflation in recent years, we think the focus may shift to essential visits only if inflationary pressures persist. The company will host its Q1 analyst call on May 12, when we expect to hear more on the near-term outlook and pet-care cost trends impacting IDXX.

$IDXX

Research157d ago

Citigroup Initiates IDEXX Laboratories at Neutral With $650 Price Target

IDEXX Laboratories (IDXX) has an average rating of overweight and mean price target of $758.38, according to analysts polled by FactSet.

$IDXX

Track with the FINWIRES app suite

FolioX

Track IDXX in your portfolio

WheelAI

Analyze IDXX options with the wheel strategy

StockInsider

See market sentiment on IDXX